Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.

SARS-CoV-2 vaccination modelling for safe surgery to save lives: Data from an international prospective cohort study

Michele Rubbini
Membro del Collaboration Group
;
Savino Occhionorelli
Membro del Collaboration Group
;
Carlo Feo
Membro del Collaboration Group
;
Angeli Christy Yu
Membro del Collaboration Group
2021

Abstract

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.
2021
Nepogodiev, Dmitri; F Simoes, Joana F; Li, Elizabeth; Glasbey, James; Picciochi, Maria; K Kamarajah, Sivesh; Gujjuri, Rohan; Bhangu, Aneel; A, Maryam; A Azab, Mohammed; A Janjua, Dratif; A Zahran, Mohammed; A Abdelaziz, Areej; Aamir, Junaid; Ab Rahman, Norhafiza; Munjih Ab Rashid, Islah; Aba Zaid, Muna; Abaalkhail, Muath; Ababneh, Adnan; Ababneh, Hazim; Ababneh, Laila; Ababneh, Roba; Abad Alonso, Rafael; Abad Gurumeta, Alfredo; Abad-Motos, Ane; Abaker, Mussab; Rainiel Abary, Ryan; Abass, Adam; Abate, Emmanuele; Abayazeed Ahmed, Sheraz; Abayomi, Olukayode; Abazeed, Alaa; Abbad, Bader; Abbadessa, Francesco; Abbadi, Osaid; Abbakar, Malaz; M Abbas, Ahmed; Salah Abbas, Alzhraa; Abbas, Asad; M Abbas, Aya; Mohamed Ali Abbas, Ferial; Abbas, Jihad; Abbas, Manzar; André, Benoît; Andreani, Lorenzo; Andreani, Stefano; Andreatta, Erika; Andrejevic, Predrag; Andreotti, Isis; Andres Imaz, Ainhoa; Andrés Ros, Conrado; Andreu Riobello, Eva; Andrews, Emmet; Andrews, Kiah; Andriamanana, Liantsoa; Andrianakis, Alexandros; E Andriantsoa, Herimampionona; Andro, Christophe; Androus, Farah; Andújar Lara, Iván; Anderson Aneke, Ikenna; Anesi, Alexandre; Anesti, Katerina; Anne Ang, Angeli; Ang, Keng-Leong; Ang, Wei-Wen; Angel, Carol; Adolfo Angel, Gustavo; Aida Angeles, Martina; Angelico, Roberta; Angelides, Sophia; Angelis, Fragkiskos; Angelou, Dimitrios; Angelou, Kyveli; Angenete, Eva; Angerer, Rafael; Angermann, Reinhard; Angles Crespo, Francesc; Angulo Artal, Raquel; Anicetti, Joshua; Bankhead-Kendall, Brittany; Banks, Thomas; Bansal, Kuldeep; Bansal, Sujesh; Banting, Simon; Bany Issa, Anas; Bany Yasin, Hammam; Banziger, Carina; Baquedano, Mai; Baquero, David; Catalin Baraian, Sergiu; Barakat, Ahmed; Barakat Awada, Jamile; Baraket, Oussama; Baral, Perel; Baran, Elif; Barat, Maxime; Baratte, Baratte; Barauskas, Vidmantas; Barbara, Frezza; Barbas, Andrew; Barbato, Giuseppe; Barberá, Rafael; Barberio, Cristina; Barberis, Andrea; Barbier, Luis; José Barbosa Camacho, Francisco; Barbosa-Breda, Joao; Barca, Ida; Barcelata Rodriguez, Indalecio; Carlos Barcelon, Jose; Bárcena, Elizabeth; Bardelli, Laura; Bareka, Metaxia; Barillas, Kathia; Barillas, Sabrina; Barisic, Goran; Barišić, Tatjana; Barker, John; Barker, Jonathan; Barkhatov, Sergey; Bridgman, Elsie; Brienze, Carolina; Bright, Tim; Brignall, Rhiannon; Zakaria Brimo Alsaman, Muhamad; Brincat, Svetlana; Briner, Lukas; Brinkler, Rebecca; Brinskelle, Petra; Britez Barrios, Edulfo; Brito, Kattiucy; Brito da Silva, Francisca; Britos, Analia; Brits, Tim; Britton, John; Britton-Zier, Linda; Brivio, Ariberto; Brixton, Genevieve; Brkic, Lucija; Broadbent, Samuel; Brobbey, Phoebe; Broe, Claire; Broecheler, Tobias; Broglia, Alessandro; Brolese, Alberto; Brolo, Estuardo; Bromage, Stephen; Brooke-Smith, Mark; Brouki Milan, Peiman; Brown, Allison; Brown, Andrew; Brown, Benjamin; Campos Carot, Elena; Campos Garcia, Juan; Idalia Campos Mejía, Denisse; Campuzano, Nicolás; Campuzano Bitterling, Borja; Camuera, Maite; Canals Sin, Mªpilar; Candan, Mert; Pauloe Candelario, Nipseey; Vidal Candia, Francisco; Candiani, Massimo; Candotti, Giorgio; Canelo Professor, Ruben; Cankoski, Dalibor; Cano Busnelli, Virginia; Caño Velasco, Jorge; Cano-Trigueros, Emiliano; Canonico, Giuseppe; Canotilho, Rita; Canovic, Samir; Cantero, Daniel; Ruano, Ana; Ruano Campos, Adriana; Rubbini, Michele; Rubbo, Sonia; Rubiano, Wilson; Rubicz, Nina; Rubio, Enrique; Rubio Manzanares Dorado, Mercedes; Rubio-Palau, Josep; Rubio-Perez, Ines; Occhionorelli, Savino; Feo, Carlo; Yu, Angeli Christy
File in questo prodotto:
File Dimensione Formato  
SARS-Cov-2 vaccination.pdf

accesso aperto

Descrizione: Full text ahead of print
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 223.16 kB
Formato Adobe PDF
223.16 kB Adobe PDF Visualizza/Apri
znab101.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 237.26 kB
Formato Adobe PDF
237.26 kB Adobe PDF Visualizza/Apri
07_BJS_2021_Appendix S1 and supplementary tables and figure.pdf

accesso aperto

Descrizione: Appendix S1 and supplementary tables and figure
Tipologia: Altro materiale allegato
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 593.75 kB
Formato Adobe PDF
593.75 kB Adobe PDF Visualizza/Apri
07_BJS_2021_Author_collaborator list.pdf

accesso aperto

Descrizione: Author_collaborator list
Tipologia: Altro materiale allegato
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 900.63 kB
Formato Adobe PDF
900.63 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2458525
Citazioni
  • ???jsp.display-item.citation.pmc??? 274
  • Scopus 86
  • ???jsp.display-item.citation.isi??? 71
social impact